Metabonomics as a Tool for Understanding Lipid Metabolism
暂无分享,去创建一个
[1] Song‐Pyo Hong,et al. Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.
[2] I. Wilson,et al. Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism , 2003, Nature Reviews Drug Discovery.
[3] Elaine Holmes,et al. A metabonomic investigation of hepatotoxicity using diffusion-edited 1H NMR spectroscopy of blood serum. , 2003, The Analyst.
[4] J Bruce German,et al. Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids. , 2003, The Journal of nutrition.
[5] U. Engelke,et al. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism , 2003, Annals of clinical biochemistry.
[6] J. Bruce German,et al. Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞s The online version of this article (available at http://www.jlr.org) contains an additional 4 tables. Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200169-JLR200 , 2002, Journal of Lipid Research.
[7] J. Liao. Beyond lipid lowering: the role of statins in vascular protection. , 2002, International journal of cardiology.
[8] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[9] W. Cromwell,et al. Measurement issues related to lipoprotein heterogeneity. , 2002, The American journal of cardiology.
[10] Alice Arnold,et al. Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[11] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[12] Elaine Holmes,et al. Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.
[13] D. Freedman,et al. Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. , 2001, Metabolism: clinical and experimental.
[14] E Holmes,et al. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. , 2001, Chemical research in toxicology.
[15] P. Wilson,et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[16] H M Davey,et al. Rapid analysis of high-dimensional bioprocesses using multivariate spectroscopies and advanced chemometrics. , 2000, Advances in biochemical engineering/biotechnology.
[17] D. Kell,et al. The deconvolution of pyrolysis mass spectra using genetic programming: application to the identification of some Eubacterium species. , 1998, FEMS microbiology letters.
[18] Mao,et al. Three-dimensional maximum-quantum correlation HMQC NMR spectroscopy (3D MAXY-HMQC) , 1997, Journal of magnetic resonance.
[19] H. Knoblauch,et al. Heritability analysis of lipids and three gene loci in twins link the macrophage scavenger receptor to HDL cholesterol concentrations. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[20] R. Gonzalez,et al. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Spraul,et al. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.
[22] Bruce L. Bush,et al. Extending the trend vector: The trend matrix and sample-based partial least squares , 1994, J. Comput. Aided Mol. Des..
[23] M. Spraul,et al. Application of the one-dimensional TOCSY pulse sequence in 750 MHz 1H-NMR spectroscopy for assignment of endogenous metabolite resonances in biofluids. , 1994, Journal of pharmaceutical and biomedical analysis.
[24] J. Coresh,et al. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. , 1993, Journal of lipid research.
[25] R. Krauss,et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. , 1992, Clinical chemistry.
[26] D W Bennett,et al. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. , 1991, Clinical chemistry.
[27] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[28] J. Goldstein,et al. The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor , 1983, Cell.